ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Non-GAAP net income: $21,768M in FY2025, up 85.3% from a year earlier. That is the highest of the 10 years on record here.
Latest, FY2025
21,768
Period ended Dec 31, 2025
Change on a year earlier
+85.3%
11,747 in FY2024
History
10 years
Since FY2016
Sources
7
Documents cited below
Where the FY2025 figure comes from
“|| Net income - Non-GAAP | $ | 6,771 | $ | 4,806 | $ | 21,768 | $ | 11,747”
Source: Earnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗
Reported in Form 8-K Earnings Releases (Non-GAAP Reconciliation Schedules).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP net income ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21,768 | +85.3% | Earnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 11,747 | +105.6% | Earnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗ |
| FY2023 | Dec 31, 2023 | 5,713 | -20.5% | Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 7,186 | -3.4% | Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗ |
| FY2021 | Dec 31, 2021 | 7,437 | +2.8% | Earnings Release (Form 8-K FY2021Q4 EX-99.1) (filed 2022-02-03) ↗ |
| FY2020 | Dec 31, 2020 | 7,236 | +30.0% | Earnings Release (Form 8-K FY2020Q4 EX-99.1) (filed 2021-01-29) ↗ |
| FY2019 | Dec 31, 2019 | 5,568 | -2.9% | Earnings Release (Form 8-K FY2020Q4 EX-99.1) (filed 2021-01-29) ↗ |
| FY2018 | Dec 31, 2018 | 5,735 | +26.6% | Earnings Release (Form 8-K FY2018Q4 EX-99.1) (filed 2019-02-06) ↗ |
| FY2017 | Dec 31, 2017 | 4,530 | +21.3% | Earnings Release (Form 8-K FY2017Q4 EX-99.1) (filed 2018-01-31) ↗ |
| FY2016 | Dec 31, 2016 | 3,736 | – | Earnings Release (Form 8-K FY2017Q4 EX-99.1) (filed 2018-01-31) ↗ |
Breakdown
What makes up non-GAAP net income
Cite this data
StockData. (2026). Eli Lilly Non-GAAP net income ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/ni-nongaap
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.